Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03471663
Title A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors InventisBio Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution Fresno California 93720 United States Details
Local Institution Aurora Colorado 80012 United States Details
Local Institution New Haven Connecticut 06511 United States Details
Local Institution Boston Massachusetts 02114 United States Details
Local Institution Eugene Oregon 97401 United States Details
Local Institution Greenville South Carolina 29605 United States Details
Local Institution Nashville Tennessee 37203-1619 United States Details
Local Institution Dallas Texas 75246 United States Details
Local Institution San Antonio Texas 78217 United States Details
Local Institution San Antonio Texas 78229 United States Details
Local Institution Tyler Texas 75702 United States Details
Local Institution Beijing Chaoyang District 100021 China Details
Local Institution Guangzhou Guangdong China Details
Local Institution Changsha Hunan Provence China Details
Local Institution Shenyang Liaoning 110042 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field